EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Amyloid Beta (Aβ) Oligomers on Blood–Brain Barrier Using a 3D Microfluidic Vasculature-on-a-Chip Model

Samuel Chidiebere Uzoechi, Boyce Edwin Collins iD, Cody Joseph Badeaux, Yan Li iD, Sang Su Kwak, Doo Yeon Kim, Daniel Todd Laskowitz, Jin-Moo Lee, Yeoheung Yun

Applied Sciences · 04.05.2024 · 14 (9) · 3917

DOI: 10.3390/app14093917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Sciences, online erschienen am 04.05.2024. Verfasst von Samuel Chidiebere Uzoechi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Biological, and Bioengineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The disruption of the blood–brain barrier (BBB) in Alzheimer’s Disease (AD) is largely influenced by amyloid beta (Aβ). In this study, we developed a high-throughput microfluidic BBB model devoid of a physical membrane, featuring endothelial cells interacting with an extracellular matrix (ECM). This paper focuses on the impact of varying concentrations of Aβ1–42 oligomers on BBB dysfunction by treating them in the luminal. Our findings reveal a pronounced accumulation of Aβ1–42 oligomers at the BBB, resulting in the disruption of tight junctions and subsequent leakage evidenced by a barrier integrity assay. Additionally, cytotoxicity assessments indicate a concentration-dependent increase in cell death in response to Aβ1–42 oligomers (LC50 ~ 1 µM). This study underscores the utility of our membrane-free vascular chip in elucidating the dysfunction induced by Aβ with respect to the BBB.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s Disease (AD)amyloid betablood–brain barriermicrofluidic

Autor:innen und Institutionen

  • Department of Chemical, Biological, and Bioengineering, North Carolina Agricultural and Technical State University, Greensboro, NC 27411, USA.
  • Department of Biomedical Engineering, Federal University of Technology, PMB 1526, Owerri 460114, Nigeria.
  • Chemical & Biomedical Engineering, College of Engineering, Florida State University, Tallahassee, FL 32310, USA.
  • Genetics and Aging Research Unit, Mass General Hospital, Harvard Medical School, 114 16th Street, Charlestown, MA 02129, USA.
  • Neurosurgery, Anesthesiology & Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.
  • Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.

ORCID-Profile: Boyce Edwin Collins, Yan Li

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Science Foundation
  • Cure Alzheimer’s Fund
  • National Institutes of Health

Zitieren

APA

Uzoechi, S. C., Collins, B. E., Badeaux, C. J., Li, Y., Kwak, S. S., Kim, D. Y., Laskowitz, D. T., Lee, J. M., & Yun, Y. (2024). Effects of Amyloid Beta (Aβ) Oligomers on Blood–Brain Barrier Using a 3D Microfluidic Vasculature-on-a-Chip Model. Applied Sciences, 14(9), 3917. https://doi.org/10.3390/app14093917

Vancouver

Uzoechi SC, Collins BE, Badeaux CJ, Li Y, Kwak SS, Kim DY, et al. Effects of Amyloid Beta (Aβ) Oligomers on Blood–Brain Barrier Using a 3D Microfluidic Vasculature-on-a-Chip Model. Applied Sciences. 2024;14(9):3917. doi:10.3390/app14093917

BibTeX
@article{Uzoechi2024,
  author = {Uzoechi, Samuel Chidiebere and Collins, Boyce Edwin and Badeaux, Cody Joseph and Li, Yan and Kwak, Sang Su and Kim, Doo Yeon and Laskowitz, Daniel Todd and Lee, Jin-Moo and Yun, Yeoheung},
  title = {Effects of Amyloid Beta (Aβ) Oligomers on Blood–Brain Barrier Using a 3D Microfluidic Vasculature-on-a-Chip Model},
  journal = {Applied Sciences},
  year = {2024},
  volume = {14},
  number = {9},
  pages = {3917},
  doi = {10.3390/app14093917}
}
Kostenlos starten →